Inventor · disambiguated record
Mark Holoboski
Also filed as: HOLOBOSKI MARK · HOLOBOSKI MARK A
22 granted patents·8 pending applications·298 citations·filing 2000–2017
95Inventor score
Top patents by PatentIndex Score
30 records- 0198US6710072B2Ω-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonistsALLERGAN INC·Filed 2002·Granted Mar 23, 2004·118 cites·29 claims
- 0292US6410591B13,7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressureALLERGAN SALES INC·Filed 2001·Granted Jun 25, 2002·40 cites·15 claims
- 0391US6376533B1Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonistsALLERGAN SALES INC·Filed 2000·Granted Apr 23, 2002·37 cites·27 claims
- 0490US6538018B13, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressureALLERGAN INC·Filed 2002·Granted Mar 25, 2003·24 cites·17 claims
- 0588US7872045B2Combination therapy for glaucoma treatmentALLERGAN INC·Filed 2005·Granted Jan 18, 2011·5 cites·2 claims
- 0688US6956057B2EP4 agonists as agents for lowering intraocular pressureALLERGAN INC·Filed 2003·Granted Oct 18, 2005·16 cites·13 claims
- 0786US6586462B2ω-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonistsALLERGAN INC·Filed 2002·Granted Jul 1, 2003·16 cites·27 claims
- 0884US6248783B1Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivatives as therapeutic agentsALLERGAN SALES INC·Filed 2000·Granted Jun 19, 2001·16 cites·14 claims
- 0981US7960378B2Therapeutic compoundsALLERGAN INC·Filed 2009·Granted Jun 14, 2011·4 cites·14 claims
- 1080US6767920B23, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressureALLERGAN INC·Filed 2003·Granted Jul 27, 2004·6 cites·16 claims
- 1172US7183324B22,3,4-substituted cyclopentanones as therapeutic agentsALLERGAN INC·Filed 2004·Granted Feb 27, 2007·5 cites·28 claims
- 1272US6307092B1Cyclopentane, 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivatives as therapeutic agentsALLERGAN SALES INC·Filed 2001·Granted Oct 23, 2001·4 cites·10 claims
- 1371US2011152328A1Combination Therapy For GlaucomaWHITCUP SCOTT M·Filed 2009·Application pending·0 cites
- 1470US7022726B2ω-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonistsALLERGAN INC·Filed 2003·Granted Apr 4, 2006·4 cites·2 claims
- 1570US6359181B1Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivatives as therapeutic agentsALLERGAN SALES INC·Filed 2001·Granted Mar 19, 2002·3 cites·8 claims
- 1662US9591935B2Therapeutic substituted cyclopentanesOLD DAVID W·Filed 2008·Granted Mar 14, 2017·0 cites·21 claims
- 1762US2014235681A1Combination therapy for glaucomaALLERGAN INC·Filed 2013·Application pending·0 cites
- 1860US7514462B2ω-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonistsALLERGAN INC·Filed 2007·Granted Apr 7, 2009·0 cites·1 claims
- 1959US2007232660A1Therapeutic and delivery methods of prostaglandin ep4 agonistsALLERGAN INC·Filed 2007·Application pending·0 cites
- 2057US2003027853A13, 7or3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressureALLERGAN SALES INC·Filed 2001·Application pending·0 cites
- 2156US7223746B2Omega cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonistsALLERGAN INC·Filed 2004·Granted May 29, 2007·0 cites·5 claims
- 2256US2013245283A1Therapeutic and delivery methods of prostaglandin ep4 agonistsALLERGAN INC·Filed 2013·Application pending·0 cites
- 2355US7964634B2Therapeutic compoundsALLERGAN INC·Filed 2009·Granted Jun 21, 2011·0 cites·8 claims
- 2454US7612082B2Prostaglandin EP4 antagonistsALLERGAN INC·Filed 2004·Granted Nov 3, 2009·0 cites·2 claims
- 2553US9765065B2Therapeutic substituted cyclopentanesALLERGAN INC·Filed 2017·Granted Sep 19, 2017·0 cites·9 claims
- 2651US8193373B2Therapeutic compoundsHOLOBOSKI MARK·Filed 2007·Granted Jun 5, 2012·0 cites·20 claims
- 2750US2010280250A1Therapeutic and delivery methods of prostaglandin ep4 agonistsALLERGAN INC·Filed 2010·Application pending·0 cites
- 2850US2005222094A1Treatment of inflammatory bowel diseaseBURK ROBERT M·Filed 2005·Application pending·0 cites
- 2948US8487091B2Substituted cyclopentanes having prostaglandin activityHOLOBOSKI MARK·Filed 2009·Granted Jul 16, 2013·0 cites·8 claims
- 3043US2008132543A1Therapeutic and Delivery Methods of Prostaglandin Ep4, AgonistsIM WHA BIN·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark Holoboski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →